IP Library › Granted Patent US 12,424,001
Granted Patent B2
US 12,424,001 · App. 17/633,116 · Granted Sep 23, 2025

Predicting patient responses to a chemical substance

Inventors: Wenzhi Cao (Seattle, WA); Yechi Ma (Lawrenceville, NJ); Qi Tang (Bridgewater, NJ)
Assignee: Sanofi
G06V20/695G06T7/0012G06V10/454G06V10/50G06V10/82G06V20/698G06T2207/20021G06T2207/20084G06T2207/30024G06T2207/30096G06V2201/03
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,424,001
App. No.
17/633,116
Filed
Feb 4, 2022
Granted
Sep 23, 2025
Kind
B2
Art Unit
2699
USPC
382/128
Abstract

In an aspect, a data processing system includes a computer-readable memory comprising computer-executable instructions, and at least one processor configured to execute executable logic including at least one artificial neural network trained to predict one or more responses to a chemical substance by identifying one or more discrete biological tissue components in a biological image. When the at least one processor is executing the computer-executable instructions, the at least one processor is configured to carry out operations including: receiving spatially arranged image data representing a biological image of a patient; generating spatially arranged image tile data representing a plurality of image tiles; processing the spatially arranged image tile data through one or more data structures storing one or more portions of executable logic included in the artificial neural network to predict one or more responses of a patient.

Claims (49)

1. A data processing system, comprising:

a computer-readable memory comprising computer-executable instructions; and

at least one processor configured to execute executable logic including an artificial neural network trained to predict a response to a chemical substance by identifying one or more discrete biological tissue components in an input biological image, wherein when the at least one processor is executing the computer-executable instructions, the at least one processor is configured to carry out operations comprising:

receiving image data representing a biological image of a patient;

processing the image data using the artificial neural network and in accordance with trained values of a set of artificial neural network parameters to generate a response score that defines a predicted response of the patient to the chemical substance, wherein the processing comprises, at each of a plurality of time steps in a sequence of time steps:

obtaining current location data for the time step that defines a location of a current patch of the biological image;

processing the current patch of the biological image using a feature extraction module of the artificial neural network to generate a feature representation of the current patch of the biological image that characterizes locations of discrete biological tissue components in the current patch of the biological image;

processing the feature representation of the current patch of the biological image using a location module of the artificial neural network to generate a next location data for a next time step that defines a location of a next patch of the biological image to be processed at a next time step; and

providing the next location data for processing at the next time step in the sequence of time steps; and

wherein the processing further comprises generating the response score that defines the predicted response of the patient to the chemical substance based on the feature representations of the patches of the biological image.

2. The data processing system of claim 1 , wherein the biological image comprises an immunohistochemistry image.

3. The data processing system of claim 1 , wherein the artificial neural network comprises a deep recurrent attention model.

4. The data processing system of claim 1 , the operations further comprising:

generating preprocessed spatially arranged image data representing a preprocessed biological image;

wherein generating preprocessed spatially arranged image data comprises identifying one or more pixels of the biological image representing one or more locations of biological tissue and color normalizing one or more locations of biological tissue.

5. The data processing system of claim 1 , wherein the predicted response of the patient to the chemical substance defines a predicted reduction in a size of a tumor.

6. The data processing system of claim 1 , wherein the feature extraction module and the location module of the artificial neural network have been jointly trained to optimize a reinforcement learning objective function.

7. The data processing system of claim 1 , wherein the chemical substance comprises a drug for treating a medical condition, wherein the patient has the medical condition.

8. A method performed by at least one processor executing executable logic including at an artificial neural network trained to predict a response to a chemical substance by identifying one or more discrete biological tissue components in an input biological image, the method comprising:

receiving image data representing a biological image of a patient;

processing the image data using the artificial neural network and in accordance with trained values of a set of artificial neural network parameters to generate a response score that defines a predicted response of the patient to the chemical substance, wherein the processing comprises, at each of a plurality of time steps in a sequence of time steps:

obtaining current location data for the time step that defines a location of a current patch of the biological image;

processing the current patch of the biological image using a feature extraction module of the artificial neural network to generate a feature representation of the current patch of the biological image that characterizes locations of discrete biological tissue components in the current patch of the biological image;

processing the feature representation of the current patch of the biological image using a location module of the artificial neural network to generate a next location data for a next time step that defines a location of a next patch of the biological image to be processed at a next time step; and

providing the next location data for processing at the next time step in the sequence of time steps; and

wherein the processing further comprises generating the response score that defines the predicted response of the patient to the chemical substance based on the feature representations of the patches of the biological image.

9. The method of claim 8 , wherein the biological image comprises an immunohistochemistry image.

10. The method of claim 8 , wherein the artificial neural network comprises a deep recurrent attention model.

11. The method of claim 8 , further comprising:

generating preprocessed spatially arranged image data representing a preprocessed biological image;

wherein generating preprocessed spatially arranged image data comprises identifying one or more pixels of the biological image representing one or more locations of biological tissue and color normalizing one or more locations of biological tissue.

12. The method of claim 8 , wherein the predicted response of the patient to the chemical substance defines a predicted reduction in a size of a tumor.

13. The method of claim 8 , wherein the feature extraction module and the location module of the artificial neural network have been jointly trained to optimize a reinforcement learning objective function.

14. The method of claim 8 , wherein the chemical substance comprises a drug for treating a medical condition, wherein the patient has the medical condition.

15. One or more non-transitory computer storage media storing instructions that when executed by one or more computers cause the one or more computers to perform operations comprising:

receiving image data representing a biological image of a patient;

processing the image data using an artificial neural network and in accordance with trained values of a set of artificial neural network parameters to generate a response score that defines a predicted response of the patient to a chemical substance, wherein the processing comprises, at each of a plurality of time steps in a sequence of time steps:

obtaining current location data for the time step that defines a location of a current patch of the biological image;

processing the current patch of the biological image using a feature extraction module of the artificial neural network to generate a feature representation of the current patch of the biological image that characterizes locations of discrete biological tissue components in the current patch of the biological image;

processing the feature representation of the current patch of the biological image using a location module of the artificial neural network to generate a next location data for a next time step that defines a location of a next patch of the biological image to be processed at a next time step; and

providing the next location data for processing at the next time step in the sequence of time steps; and

wherein the processing further comprises generating the response score that defines the predicted response of the patient to the chemical substance based on the feature representations of the patches of the biological image.

16. The non-transitory computer storage media of claim 15 , wherein the biological image comprises an immunohistochemistry image.

17. The non-transitory computer storage media of claim 15 , wherein the artificial neural network comprises a deep recurrent attention model.

18. The non-transitory computer storage media of claim 15 , wherein the operations further comprise:

generating preprocessed spatially arranged image data representing a preprocessed biological image;

wherein generating preprocessed spatially arranged image data comprises identifying one or more pixels of the biological image representing one or more locations of biological tissue and color normalizing one or more locations of biological tissue.

19. The non-transitory computer storage media of claim 15 , wherein the predicted response of the patient to the chemical substance defines a predicted reduction in a size of a tumor.

20. The non-transitory computer storage media of claim 15 , wherein the feature extraction module and the location module of the artificial neural network have been jointly trained to optimize a reinforcement learning objective function.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2022
From: TANG, QI; MA, YECHI; CAO, WENZHI
To: SANOFI
Reel/Frame 059067/0524 →
Priority Claims (1)
EP 20305030 · Jan 16, 2020 · regional
Continuity (2)
Provisional Application 62886199 · Aug 13, 2019
Related Publication 20220318993A1 · Oct 6, 2022
References Cited (31)
US 11741365B2 · Khan · 2023 [cited by examiner]
US 20140297199A1 · Osten · 2014 [cited by applicant]
US 20170169567A1 · Chefd'Hotel et al. · 2017 [cited by applicant]
US 20190204088A1 · Haque · 2019 [cited by examiner]
US 20190206056A1 · Georgescu et al. · 2019 [cited by applicant]
US 20200272864A1 · Faust · 2020 [cited by examiner]
US 20200388029A1 · Saltz · 2020 [cited by examiner]
US 20210081821A1 · Sasaki · 2021 [cited by examiner]
US 20230143701A1 · Bauchet · 2023 [cited by examiner]
JP 2015507470A · 2015 [cited by applicant]
WO WO2013071099 · 2013 [cited by applicant]
WO WO2018156133 · 2018 [cited by applicant]
Ngiam et al., “Tiled convolutional neural networks,” Advances in Neural Information Processing Systems, Dec. 9, 2010, 23:1279-1287. [cited by applicant]
Rawat et al., “Deep convolutional neural networks for image classification: A comprehensive review,” Neural computation, Aug. 24, 2017, 29(9):2352-2449. [cited by applicant]
Anonymous, “Color Normalization,” Jul. 15, 2019, retrieved on Feb. 14, 2022, retrieved from URL<“https://en.wikipedia.org/w/index.php?title=Color_normalization&oldid=906448932”>, 6 pages. [cited by applicant]
BenTaieb et al., “Predicting Cancer with a Recurrent Visual Attention Model for Histopathology Images,” MICCAI 2018: Medical Image Computing and Computer Assisted Intervention, Sep. 2018, pp. 129-137. [cited by applicant]
Bychkov et al., “Deep learning based tissue analysis predicts outcome in colorectal cancer,” Scientific Reports, Feb. 2018, 8(3395): 1-11. [cited by applicant]
fda.gov [online], “FDA expands pembrolizumab indication for first-line treatment of NSCLC (TPS 1%),” Apr. 11, 2019, retrieved on Feb. 14, 2022, retrieved from URL <“https://www.fda.gov/drugs/fda-expands-pembrolizumab-in… [cited by applicant]
Hamilton et al., “Digital pathology and image analysis in tissue biomarker research,” Methods, Nov. 2014, 70(1): 59-73. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/US2020/045624, dated Oct. 19, 2020, 12 pages. [cited by applicant]
Janowczyk et al., “Deep learning for digital pathology image analysis: A comprehensive tutorial with selected use cases,” Journal of Pathology Informatics, Jul. 2016, 7:29, 18 pages. [cited by applicant]
Kato et al., “Counterpoint: Successes in the Pursuit of Precision Medicine: Biomarkers Take Credit,” Journal of the National Comprehensive Cancer Network, Jul. 2017, 15(7): 863-866. [cited by applicant]
Komura et al., “Machine Learning Methods for Histopathological Image Analysis,” Computational and Structural Biotechnology Journal, 2018, 16: 34-42. [cited by applicant]
LeCun et al., “Deep learning,” Nature, May 2015, 521: 436-444. [cited by applicant]
Litjens et al., “A survey on deep learning in medical image analysis,” Medical image Analysis, Dec. 2017, 42: 60-88. [cited by applicant]
Madabhushi et al., “Image analysis and machine learning in digital pathology: Challenges and opportunities,” Medical Image Analysis, Oct. 2016, 33: 170-175. [cited by applicant]
Mobadersany et al., “Predicting cancer outcomes from histology and genomics using convolutional networks,” Proceedings of the National Academy of Sciences of the United States of America, Mar. 2018, 115(13): E2970-E2979. [cited by applicant]
Momeni et al., “Deep Recurrent Attention Models for Histopathological Image Analysis,” bioRxiv, Oct. 2018, 5 pages. [cited by applicant]
Peters et al., “PD-1 blockade in advanced Nsclc: A focus on pembrolizumab,” Cancer Treatment Reviews, Jan. 2018, 62: 39-49. [cited by applicant]
Silva et al., “PD-L1 immunostaining scoring for non-small cell lung cancer based on immunosurveillance parameters, ” PLOS One, Jun. 2018, 13(6): e0196464, 15 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/US2020/045624, dated Feb. 24, 2022, 10 pages. [cited by applicant]